Remove Dermatitis Remove Eczema Remove Office
article thumbnail

NEA Study Seeks to Refine Definition of Eczema Flares: Here’s What They Found

The Dermatology Digest

What is an eczema flare? Flare is commonly used in eczema care and clinical research, but there’s been little agreement on what it means until now. Focus group participants were mostly female (69%), Asian or Asian American (35%), 18–35 years old (62%) and diagnosed with eczema in childhood (83%).

Eczema 36
article thumbnail

Navigating Eczema: How a Dermatologist Can Help Manage Atopic Dermatitis

US Dermatologt Partners

Atopic Dermatitis, more commonly known as eczema, is a common skin condition impacting one in 10 Americans. Dermatology Partners affiliate office Medical Dermatology Specialists in Phoenix, Arizona , “Like other chronic skin conditions, eczema is best managed with the help of a dermatologist.

Eczema 36
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NEA Survey: Fully Half of AD Patients Never Asked About Mental Health

The Dermatology Digest

Eczema is known to take a toll on emotional wellbeing and quality of life, yet 42% of patients with atopic dermatitis (AD) and caregivers of children/teens with eczema have never spoken about mental health with primary eczema care providers, according to new survey results from The National Eczema Association (NEA) in Skin Health and Disease.

Eczema 36
article thumbnail

Dermavant Submits Supplemental sNDA to FDA for VTAMA Cream for AD in Adults and Children 2 Years of Age and Older  

The Dermatology Digest

and is the same strength and formulation studied in the ADORING Phase 3 development program and included in the sNDA submission for atopic dermatitis. Dermavant Sciences has submitted a Supplemental New Drug Application (sNDA) to the U.S. VTAMA cream, 1% is currently approved for the topical treatment of plaque psoriasis in adults in the U.S.

article thumbnail

Oh, The Places Dermatology Will Go in 2024!

The Dermatology Digest

Peter Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, agrees that it is going to be a big year for eczema patients and the doctors who treat them. “I Taking Seb Derm Seriously The U.S.

article thumbnail

NEA Scores $250,000 Engagement Award From PCORI

The Dermatology Digest

The National Eczema Association (NEA) has been approved for a $250,000 funding award through the Eugene Washington PCORI Engagement Award Program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI). The PCORI Engagement Award will be directed by Wendy Smith Begolka, MBS, chief strategy officer at NEA and Jessica K.

Eczema 36
article thumbnail

AD Pipeline Watch: Aslan Reports “Spectacular Results” in Phase 2 Study of Eblasakimab That Included Some Dupilumab-experienced Patients

The Dermatology Digest

Adult atopic dermatitis (AD) patients previously treated with dupilumab (Dupixent, Regeneron and Sanofi) who received 400mg eblasakimab weekly achieved Eczema Area Severity Index (EASI) 90, and 66.7% achieved a Validated Investigator Global Assessment (vIGA) score of 0 or 1 after 16 weeks compared to 14.3%